Supplementary Data S2 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML

Supplementary Data S2 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML

<p>Raw RNAseq data corresponding to Figures 2C, 4D and Supplemental Figure 2B</p>

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Christopher T. Letson (16424095) (author)
Άλλοι συγγραφείς:	Maria E. Balasis (15033630) (author), Hannah Newman (15033618) (author), Moritz Binder (16424098) (author), Alexis Vedder (16424101) (author), Fumi Kinose (16424104) (author), Markus Ball (15033633) (author), Traci Kruer (15134201) (author), Ariel Quintana (16424107) (author), Terra L. Lasho (16424110) (author), Christy M. Finke (16424113) (author), Luciana L. Almada (16424116) (author), Jennifer M. Grants (16424119) (author), Guolin Zhang (15098544) (author), Martin E. Fernandez-Zapico (16424122) (author), Alexandre Gaspar-Maia (16424125) (author), Jeffrey Lancet (16424128) (author), Rami Komrokji (16424131) (author), Eric Haura (16424134) (author), David A. Sallman (15134216) (author), Gary W. Reuther (16424137) (author), Aly Karsan (15024852) (author), Uwe Rix (15040221) (author), Mrinal M. Patnaik (16424140) (author), Eric Padron (15134222) (author)
Έκδοση:	2025
Θέματα:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Cell Signaling Growth factors Gene Regulation Posttranscriptional and translational control Hematological Cancers Leukemias Translational Research
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

Supplementary Data S1 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
ανά: Christopher T. Letson (16424095)
Έκδοση: (2025)

Supplementary Table S1 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
ανά: Christopher T. Letson (16424095)
Έκδοση: (2025)

Supplementary Table S2 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
ανά: Christopher T. Letson (16424095)
Έκδοση: (2025)

Supplementary Table S3 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
ανά: Christopher T. Letson (16424095)
Έκδοση: (2025)

Table S1 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
ανά: Yun-Guang Hong (14960966)
Έκδοση: (2025)

Table S2 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
ανά: Yun-Guang Hong (14960966)
Έκδοση: (2025)

Table S3 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
ανά: Yun-Guang Hong (14960966)
Έκδοση: (2025)

Table S4 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
ανά: Yun-Guang Hong (14960966)
Έκδοση: (2025)

Table S5 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
ανά: Yun-Guang Hong (14960966)
Έκδοση: (2025)

Table S6 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
ανά: Yun-Guang Hong (14960966)
Έκδοση: (2025)

Supplementary Tables S1-S4 from A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia
ανά: Fengbiao Zhou (15123670)
Έκδοση: (2025)

Supplementary Tables S1-5 from METTL3-Mediated m<sup>6</sup>A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL
ανά: Yiming Wu (15306005)
Έκδοση: (2025)

Supplementary Proteomics Data 1 from ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation
ανά: Chao Shen (22548301)
Έκδοση: (2025)

Supplementary Tables from Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
ανά: Elizabeth A. Raupach (21718352)
Έκδοση: (2025)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
ανά: Ana Vujovic (15207479)
Έκδοση: (2025)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
ανά: Ana Vujovic (15207479)
Έκδοση: (2025)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
ανά: Ana Vujovic (15207479)
Έκδοση: (2025)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
ανά: Ana Vujovic (15207479)
Έκδοση: (2025)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
ανά: Ana Vujovic (15207479)
Έκδοση: (2025)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
ανά: Ana Vujovic (15207479)
Έκδοση: (2025)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
ανά: Ana Vujovic (15207479)
Έκδοση: (2025)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
ανά: Ana Vujovic (15207479)
Έκδοση: (2025)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
ανά: Ana Vujovic (15207479)
Έκδοση: (2025)

Figure S1 from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
ανά: Christopher August Lucchesi (21643673)
Έκδοση: (2025)

Figure S2 from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
ανά: Christopher August Lucchesi (21643673)
Έκδοση: (2025)

Figure S3 from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
ανά: Christopher August Lucchesi (21643673)
Έκδοση: (2025)

Figure S4 from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
ανά: Christopher August Lucchesi (21643673)
Έκδοση: (2025)

Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
ανά: Jonathan M.J. Derry (16648337)
Έκδοση: (2025)

Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
ανά: Jonathan M.J. Derry (16648337)
Έκδοση: (2025)

Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
ανά: Jonathan M.J. Derry (16648337)
Έκδοση: (2025)

Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
ανά: Jonathan M.J. Derry (16648337)
Έκδοση: (2025)

Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
ανά: Jonathan M.J. Derry (16648337)
Έκδοση: (2025)

Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
ανά: Jonathan M.J. Derry (16648337)
Έκδοση: (2025)

Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
ανά: Jonathan M.J. Derry (16648337)
Έκδοση: (2025)

Table S1 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
ανά: Xun-Xi Lu (14952883)
Έκδοση: (2025)

Table S2 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
ανά: Xun-Xi Lu (14952883)
Έκδοση: (2025)

Table S3 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
ανά: Xun-Xi Lu (14952883)
Έκδοση: (2025)

Table S7 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
ανά: Xun-Xi Lu (14952883)
Έκδοση: (2025)

Table S8 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
ανά: Xun-Xi Lu (14952883)
Έκδοση: (2025)

Supplementary Figure 1 from The Integrated Stress Response Pathway Coordinates Translational Control of Multiple Immune Checkpoints in Lung Cancer
ανά: Shayna Thomas-Jardin (21718061)
Έκδοση: (2025)